News

FDA Grants Breakthrough Therapy Designation For Genentech’s Alecensa ®

Genentech, a member of the Roche Group, announced on October 3, 2016 that it has received a second Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase ...
Read More

Ten Essential Facts about Lung Cancer

Did you know that lung cancer is the leading cause of cancer deaths in the U.S. but is the least funded? Read more essential facts about lung cancer in this presentation and learn what you ...
Read More

Genentech’s cancer immunotherapy TECENTRIQTM (atezolizumab) helped people with a specific type of lung cancer live significantly longer compared to chemotherapy

The latest news on Genentech's immunotherapy molecule Tecentriq (atezolizumab) for NSCLC: Genetech’s Phase III Study, OAK, helped people with a specific type of lung cancer live significantly longer compared to chemotherapy, demonstrating significant improvement in ...
Read More

Lung Cancer Research Council hosts 4th annual SW Florida 5K Run/Walk Nov. 5

The Lung Cancer Research Council will host its fourth annual SW Florida 5K Run/Walk and Mile of Memories Memorial Walk on Nov. 5 at the Charlotte Sports Park, located at 2300 El Jobean Rd. in ...
Read More